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Structural Biology and Structural Bioinformatics are two complementary areas 
that deal with three dimensional structures of biomolecules. With the advent of 
high-throughput techniques and automation of identifying structures there is a 
barrage of data generated currently, which fall under the area of Big Data. In 
this review, we present examples and current approach to handle massive 
volume of structural data and some potential applications of Big Data from 
Structural Bioinformatics perspective.  
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1. INTRODUCTION 
Basic characteristics of Big Data are: Volume, Velocity, Variety, Variability, and Complexity. Any data that is 
enormous in size (i.e. large in volume) must have diverse nature making it difficult to mine and analyze. The 
speed of generation of these data should ideally be continuous and massive, which further increases the 
complexity to mange and organize the data [1]. In general, Big Data describes a holistic approach that includes 
and integrates various new-fangled types of data and data management besides traditional data. 
 
Advent in robotics, automation, and emerging technologies in the field of structural biology and structural 
bioinformatics in recent years has resulted in increase in the volume, variety and complexity of data generated. 
More specifically, the X-ray free electron laser (XFEL) would collect thousands of electron diffraction data for 
each protein, where a stream of intense X-ray can capture the fast biological process using small or micro 
crystals. It is estimated that ~10 million x-ray images can be generated within 48 hours, and ~150-200 petabytes 
of data will be generated within a few years [2]. Thus, new technologies of structural biology and the data 
generated bring them under the category of Big Data.  
 
2. Protein Sequence and Structural data is Big Data 
The Protein Data Bank (PDB) was established as a digital data source with open accessibility providing a single 
gateway to access biomolecules’ structures. Deposition of three-dimensional (3D) structural data has 
tremendously increased in the last five years (2012-2016) resulting in increased variety of data (i.e., source of 
generation; X-ray, NMR, Electron microscopy), complexity, volume, and speed of submission as reflected by 
the total and different structures deposited each year (Figure 1). The rate of submission of new structures is in 
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the range of 8000-10000 per year. Having all the basic characteristics as of Big Data, protein 3D information 
requires the incorporation of multiple approaches required to analyze them. For example, BioMagResBank, 
Protein Data Bank Japan, Protein Data Bank in Europe, and RCSB PDB in partnership has epitomized how an 
international association can efficiently deal with Big Data as a freely available public that helps in further 
advances in fundamental and applied research and learning globally. 
 
 
Figure 1: Five year cumulative growth of structures deposited in PDB. A cumulative plot of structures 
deposited in PDB is indicated in terms of type of molecule (DNA, RNA, Protein, and Protein Nucleic Acid 
Complex), where ~8000-10000 structures are deposited every year. 
 
Since 2016, a modified format of PDB files (PDBx/mmCIF) has been incorporated to include structures that 
have more than 62 chains and more than 99,999 atom records. For example, the logistical problem came in 
forefront while submitting the structure of ribosome and for large viruses. With cryo-EM techniques solving 
high resolution structures (below 2Å) depositing them in PDB creates problems in accessing the data in 
developing countries that do not have high bandwidth internet access. In May 2013, two complete HIV capsid 
structures (PDB id: 3J3Q and 3J3Y) solved by cryo-EM method were deposited containing more than 100 
chains, comprising two million atoms, each. The PDBx/mmCIF format, while following the already existing 
mmCIF format, does not restrict limitations on number of atoms, residues, or chains thereby removing the 
requirement of submitting split entries, as in the case of ribosome structure. Each file consists of categories or 
entities that in turn have sub categories that describe the various features. Due to its presentation in key-value 
form (i.e., tabular form) and use of context-free grammar parsing data from this format is easier. Also, the 
availability of meta-data makes it versatile format for programmers [3].  
 
On the other hand, structural bioinformatics deals with analysis, prediction, and manipulation of data generated 
from structural biology projects. There has been significant gain in filling the diverse knowledge gaps with the 
available structures, using structural bioinformatics tools and algorithms [4]. Currently, PDB holds more than 
100,000 structures. However, the protein sequence data is 810 times larger, accessed via Uniprot and NCBI. The 
one-dimensional information of protein sequence is also complex, varied, voluminous, and with recent advent in 
sequencing methods more sequences are being deposited (~7 x 106 to ~19 x 106 sequences in last five years). 
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3. Conventional methods to access Big Data 
The difficulties in storing and accessing the data can be taken care of by the use of client server architecture 
where data is distributed among several devices and is accessible via local network. Currently, there are tools 
available to perform the same using different file systems approach namely: cluster, parallel, and distributed file 
systems. In parallel and cluster file systems, several processes can concurrently read and write a single file. 
While, distributed file systems comprises disk arrays connected to I/O servers through fast networks followed 
by sharing it to the further nodes of a cluster.  
 
Lustre (http://lustre.org/) and General Parallel File System (GPFS) are two of the highest performance parallel 
file systems that can dynamically store data (least accessed data to cost effective storage) thereby making space 
for important data in expensive storage. Hadoop Distributed File System (HDFS) (http://hadoop.apache.org/)  
can achieve the same by spanning through large clusters of commodity servers and also making use of 
MapReduce approach to move the code to the data on a large, distributed system than to send all the data to the 
code.  
 
In order to develop user specific solutions, many open source frameworks like, Hadoop 
(http://hadoop.apache.org/), Disco (http://discoproject.org/), Strom (http://storm.apache.org/), and Apache Spark 
were developed. However, Hadoop (has become synonymous with Big Data) and the programming model of 
MapReduce can be tedious to master for few tasks. Overcoming this limitation, Apache Spark does not depend 
on MapReduce and is comparatively 10 times faster on disk and 100 times faster in memory than Hadoop [5].  
 
In past few years, HPC clusters facilitate the Big Data analysis on traditional platforms by accessing grid 
computing. However, the limitation of providing computational customization as per the user is one of the 
foremost disadvantages. This has led to increased importance of cloud computing services to perform large-
scale analysis. Cloud computing, Xeon Phi, GPU computing, and Cluster computing are chief bioinformatics 
applications that makes use of these platforms. To handle the vast amount of data being generated by high 
throughput technologies, a new approach of moving in-house data to cloud computing is done to analyze the 
data in more efficient manner. Xeon Phi, on the other hand, is based on Intel’s Many Integrated Core (MIC) to 
perform the analysis but its dependency on parallelization paradigm and lower clock frequency affecting the 
long sequential part of an application makes it not fit for native mode. In contrast, GPU computing represents a 
relative inexpensive and powerful solution with high floating performance and parallelism and therefore 
motivated by the stipulation of game industries. In present, the comparison between best devices of GPU 
computing and Xeon Phi shows on average 30% more performance of the early one [6]. Cluster computing uses 
the data parallel approach, subdivision of data for analysis through independent process, which makes it highly 
scalable for many kind of Big Data analysis. 
 
4. Current Advances in accessing Big Data: Application to Structural Bioinformatics 
The PDB archive is technically a Big Data, and it become tedious to perform large-scale structural calculations 
such as geometric queries or structural comparisons, transmit and visualize 3D structure of biological 
macromolecules and store it efficiently. To overcome these drawbacks a new compact binary format, 
Macromolecular Transmission Format (MMTF), has been developed to store and transmit biomolecular 
structural data quickly (https://mmtf.rcsb.org/). For example, the PDB archive comprising of ~29 GB in mmCIF 
format can be stored fewer than ~7 GB using the MMTF format. Besides, it makes the analysis easier and 
simple as it contains pre-calculated information and thus it occupies less space and time. Specifically, the 
parsing time for the HIV viral capsid (PDB id: 3J3Q) was estimated to take 400 minutes and the same entry in 
the binary MMTF format was parsed within seconds (https://mmtf.rcsb.org/).  It contains various fields such as 
format data, structure data, model data, chain data, group data and atom data. MMTF uses Java, Python and 
JavaScript for its implementation. The implementation of MMTF format from a normal data is schematically 
shown in Figure 2.  
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Figure 2: Converting normal data into MMTF format. Flowchart demonstrating the conversion 
methodology used to convert large data into MMTF format to store and parse it in an easier way (Adapted from 
https://mmtf.rcsb.org).   
 
In the recent past, many applications of structural bioinformatics have dealt with large scale data analysis. For 
example, metagenomics data was used for de novo prediction of protein structures. However, methods required 
in extraction of high quality protein sequences and to distinguish between intra and inter chain contacts still 
presents cumbersome challenges in the path of de novo structure prediction of proteins [7, 8]. 
In order to analyze Big Data generated via experiments and complement the existing data numerous tools have 
been developed recently. Availability of such tools, although specific to their applications, will help in 
transcending the barrier from user point of view. For example, msBiodat is a web based tool that merges the 
data available in public databases with that of mass spectrometry results generated via high-throughput methods, 
resulting in much more precise list of proteins based on their annotations and conditions and help in pin pointing 
their biological processes [9]. 
 
Similarly, TFBSbank is a platform where transcription factor and DNA interactions are compiled. It consists of 
1870 ChIP data from Drosophila, C. elegans, Human, M. musculus, and S. cerevisiae has been integrated along 
with analysis of co-binding, motif enrichment, and cofactor prediction. To counter the data-increasing day-by-
day, de novo prediction of motifs present in transcription factors and their respective functional annotation is 
performed using chip-set data. This helped in analysis of transcription factors reported and left unannotated, 
since they are responsible for controlling gene expression [10]. 
 
SBGrid, a consortium that provides a curated suite of crystallographic software and packages, has an active 
community across the world. The SBGrid community allows storage, handling, and analysis of huge datasets 
collected from the primary source of crystallographic data collection. They have established a centralized data 
publication service called Structural Biology Data Grid (SBDG) where structural coordinates, diffraction image 
data sets can be published and disseminated. It is estimated that 48 Petabytes of storage are required to store 
crystallographic images for 100,000 structures [11]. Such consortium based efforts will aid the scientific 
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community to not limit with data management problems; rather the presence of global infrastructure will 
demonstrate a cost-effective strategy to manage crystallographic Big Data. 
 
5. Big Data for Drug Discovery 
 
Drug discovery pipeline is an important application for Big Data research in structural bioinformatics. The most 
common approach of one target screened against millions of drugs in silico by molecular docking simulations 
has resulted in many successful lead and drug development stories. However, pharmacogenomic approaches for 
drug development require integrating multiple sources of information (genomic, proteomic, and other omics) 
data to drive a systems level approach towards drug development. Currently, the number of FDA approved 
drugs that include the pharacogenomic biomarkers in their labels are more than 138 [12].  The large number of 
samples with gene expression profile can be treated as Big Data and can be efficiently managed by organizing 
them in clusters with co-related expression patterns. Incorporating other associated data for the same set of 
genes with the pre-existing expression profiles will aid in accelerating the goal of personalized medicine [13]. 
 
Developing new methods that change the paradigm of data handling is the need of the hour for drug discovery. 
For example, Yabuuchi et al aimed to use the 1060 compound chemical space along with multiple large scale 
compound-protein interaction databases that are available to visualize and characterize the full complexity of 
interactions [14]. Thus, effective use of big data along with development of new methods to integrate and 
incorporate other resources should be done in order to evaluate and visualize the potential lead molecules for 
drug development. 
 
6. CONCLUSION 
 
As with any data that is sourced from others, there are some caveats or rules that apply. Recently, Zook et al 
came up with 10 simple rules for handling and conducting responsible research with Big Data. Specifically, they 
caution about ethics, privacy, weaknesses, and accountability with respect to Big Data research [15]. Big Data 
and its analytics with respect to structural biology and structural bioinformatics has been gaining attention and 
efforts are being made to develop tools/methods and algorithms that reduce the burden of data management, 
archival, and accessibility. We have highlighted some of the key examples that tackle these issues, specifically 
for handling protein sequence and structure information.  
 
Due to lack of experimental evidences, many protein structures are yet to be solved and a method that can fill 
this gap is using homology modeling. While ModBase and other databases are progressing to generate models 
automatically, the accumulation of predicted models and experimental structures will have effect in the way 
these are accessed. Also, many groups publish coarse-grained and fine-grained simulation data for single and for 
huge complexes. With the push from many journals for data storage and reproducibility, quantitative and 
qualitative data also needs attention and practical solutions for their accessibility. 
 
While, there is an enormous quantity of protein structures, the presence of mutated protein structures in equal 
measures is lacking in PDB. In developing countries, such as India, Big Data analytics in the area of Structural 
Biology and Structural Bioinformatics are in its nascent stages. However, with time it is estimated that the 
concurrent use of cloud-based networks with high-level machine learning approaches and computational 
methods for feature identification and validation can improve efficiency and reduce the cost of storage and 
managing Big Data.  
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